Drug Pipeline

ADX-038 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
4
Recruiting
1
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
2
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06960213 STOP-HAE: A Phase 3 Study of ADX-324 in HAE Hereditary Angioedema Recruiting
Phase 2
NCT06990269 Phase 2 Study of ADX-038 in Participants With Geographic Atrophy Geographic Atrophy Secondary to Age-related Macular Degeneration Recruiting
NCT07522099 Chinese Adults With Kidney Disease Immunoglobulin A Nephropathy (IgAN) Recruiting
Phase 1/2
NCT05876312 Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal… Paroxysmal Nocturnal Hemoglobinuria (PNH) Recruiting
NCT05691361 Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema… Hereditary Angioedema Active, Not Recruiting
Phase 1
NCT06205628 Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension Hypertension Active, Not Recruiting
Sponsors Running ADX-038 Trials
Disease Areas
Get alerts when ADX-038 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free